Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BOUT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BOUT investment potential.

What is BOUT stock price today?

Get real-time BOUT stock price, historical data, and price charts on Financhill. Track BOUT performance with our advanced analysis tools.

Is BOUT a good investment?

Evaluate BOUT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BOUT stock?

To buy BOUT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BOUT?

View detailed market capitalization data and company valuation metrics for BOUT on our comprehensive analysis page.

What is the P/E ratio of BOUT?

Use our fundamental analysis tools to view BOUT P/E ratio and compare valuation metrics with industry peers.

What are BOUT earnings?

View BOUT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Innovator IBD Breakout Opportunities ETF 10K Form

Buy

BOUT
Innovator IBD Breakout Opportunities ETF

Last Price:

$36.98

Seasonality Move:

3.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BOUT News And Ratings

See the #1 stock for the next 7 days that we like better than BOUT

BOUT Financial Statistics

Sales & Book Value

Annual Sales:	--
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$0.00
Price / Book:	0

Profitability

Net Income (TTM):	$0
Gross Margin:	--
Return on Equity:	0%
Return on Assets:	0%

Innovator IBD Breakout Opportunities ETF Earnings Forecast

Key Innovator IBD Breakout Opportunities ETF Financial Ratios

Innovator IBD Breakout Opportunities ETF Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSEARCA
Current Symbol:	BOUT

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

BOUT Technical Analysis vs Fundamental Analysis

Buy

Innovator IBD Breakout Opportunities ETF (BOUT) is a Buy

Is Innovator IBD Breakout Opportunities ETF a Buy or a Sell?

Innovator IBD Breakout Opportunities ETF stock is rated a Buy

The current Innovator IBD Breakout Opportunities ETF [BOUT] share price is $36.91. The Score for BOUT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.